Stock ORT B ORTOMA AB (PUBL)
Add to a list
To use this feature you must be a member
Log inSign up

Ratings Ortoma AB (publ) NORDIC GROWTH MARKET

Equities

ORT B

SE0005676103

End-of-day quote NORDIC GROWTH MARKET
Other stock markets
 18:00:00 2023-02-21 EST 		5-day change 1st Jan Change
5.76 SEK +1.41% Intraday chart for Ortoma AB (publ) +3.60% -22.16%
05-23 Ortoma AB Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
02-20 Ortoma AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 CI

Summary

  • The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
  • From a short-term investment perspective, the company presents a deteriorated fundamental configuration.

Strengths

  • Analysts expect a sharply increasing business volume for the group, with high growth rates in the coming years.
  • Thanks to a sound financial situation, the firm has significant leeway for investment.
  • Over the past year, analysts have regularly revised upwards their sales forecast for the company.
  • For the past year, analysts covering the stock have been revising their EPS expectations upwards in a significant manner.
  • The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.

Weaknesses

  • The potential for earnings per share (EPS) growth in the coming years appears limited according to current analyst estimates.
  • The company's profitability before interest, taxes, depreciation and amortization characterizes fragile margins.
  • The company has insufficient levels of profitability.
  • With an enterprise value anticipated at 2.82 times the sales for the current fiscal year, the company turns out to be overvalued.

Ratings chart - Surperformance

Sector: Advanced Medical Equipment & Technology

1st Jan change Capi. Investor Rating ESG Refinitiv
ORTOMA AB (PUBL) Stock Ortoma AB (publ)
-22.16% 28.43M -
VEEVA SYSTEMS INC. Stock Veeva Systems Inc.
-4.29% 29.79B
C
PRO MEDICUS LIMITED Stock Pro Medicus Limited
+45.89% 9.69B
C-
SECTRA AB Stock Sectra AB
+37.80% 4.5B
B-
EVOLENT HEALTH, INC. Stock Evolent Health, Inc.
-37.06% 2.38B
C-
VERADIGM INC. Stock Veradigm Inc.
-8.01% 1.63B -
C+
OMNICELL, INC. Stock Omnicell, Inc.
-30.32% 1.2B
B
SIMULATIONS PLUS, INC. Stock Simulations Plus, Inc.
+6.59% 953M
C
LUNIT INC. Stock Lunit Inc.
-41.51% 992M -
B-SOFT CO.,LTD. Stock B-SOFT Co.,Ltd.
-45.19% 763M -
Investor Rating
Trading Rating
ESG Refinitiv
-

Financials

Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances

Valuation

P/E ratio
-
EV / Sales
Price to Book
-
Price to Free Cash Flow
-
Yield
-

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
-
12m Revision of opinion
-

Business Predictability

Analyst Coverage
Divergence of Estimates
-
Divergence of analysts' opinions
-
Divergence of Target Price
-
Earnings quality
-
  1. Stock Market
  2. Equities
  3. ORT B Stock
  4. ORT B Stock
  5. Ratings Ortoma AB (publ)